Cardiotrophin 1: Difference between revisions
CSV import |
CSV import |
||
| Line 29: | Line 29: | ||
[[Category:Neurology]] | [[Category:Neurology]] | ||
{{protein-stub}} | {{protein-stub}} | ||
{{No image}} | |||
Revision as of 09:51, 10 February 2025
Cardiotrophin 1 (CT-1) is a cytokine protein that is part of the interleukin 6 (IL-6) family. It is encoded in humans by the CTF1 gene. Cardiotrophin 1 is known for its role in cardiac development and function, as well as its involvement in various pathophysiological processes.
Function
Cardiotrophin 1 is a secreted protein that signals through the glycoprotein 130 (gp130)/leukemia inhibitory factor receptor (LIFR) complex. It is involved in a variety of biological processes, including cell proliferation, cell differentiation, and apoptosis. CT-1 is particularly important in the heart, where it promotes cardiomyocyte survival and growth, and helps to regulate the heart's response to damage or stress.
Clinical significance
Alterations in the expression or function of cardiotrophin 1 have been implicated in a number of diseases. For example, elevated levels of CT-1 have been found in patients with heart failure, suggesting that it may play a role in the pathogenesis of this condition. In addition, studies have shown that CT-1 can promote the survival of neurons, suggesting potential therapeutic applications in neurodegenerative diseases such as Parkinson's disease and Alzheimer's disease.
Research
Research into cardiotrophin 1 is ongoing, with studies investigating its role in various diseases and potential therapeutic applications. For example, researchers are exploring the possibility of using CT-1 as a treatment for heart failure, based on its ability to promote cardiomyocyte survival and growth.
See also
References
<references group="" responsive="1"></references>
